Julian Upton

Julian Upton is a contributing editor for Pharmaceutical Executive.


Data Vigilance and Validation: Lessons Learned, Future Hopes for Real-World Data

Biopharma experts at the forefront of applying real-world data and real-world evidence across the product life cycle converge to discuss the lingering challenges in fully realizing the vast potential of these insights to transform the value equation.

Roads Less Traveled

After helping lead Novo Nordisk on a transformational journey from a troubled 2016 to double-digit growth in 2021, Doug Langa, Executive Vice President, Head of North America Operations and President of Novo Nordisk, Inc., is calling on his experience of taking the less conventional and sometimes unexpected routes to success to lead Novo Nordisk into new territory.

The Human Factor in Data Security Breaches

A new report examining pharma sector exposure makes for sobering reading, especially in US.